Oncolysin CD6: Began Phase I study

ImmunoGen Inc. (IMGN) Product: Oncolysin CD6, an anti-CD6 antibody linked to blocked ricin Indication: Blocking of CD6+ T cells in patients with cutaneous T cell lymphoma Status: Began Phase I study ...